Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

SCH-900776 sensitizes cancer cells to hydroxyurea and gemcitabine

April 21, 2010

LCL-161 well tolerated in ongoing first-in-human study

April 21, 2010

MTD of EMD-534085 established in phase I trial in advanced solid tumors and lymphoma

April 20, 2010

Nerviano Medical Sciences discloses new pim-1 and pim-2 kinase inhibitors

April 20, 2010

NVP-LDE-225: a newly discovered therapeutic candidate for Gorlin's syndrome / News in Context

April 20, 2010

FDA approves Tarceva as maintenance therapy for advanced non-small cell lung cancer

April 19, 2010

Cell Therapeutics nears MAA submission for pixantrone in E.U.

April 19, 2010

Updated phase I data presented on JI-101 in solid tumors

April 19, 2010

PhytoMedical signs letter of intent with Medicilon for studies on brain cancer drug candidate

April 19, 2010

Celgene and Agios collaborate to develop cancer metabolism programs

April 19, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...